John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

Oppenheimer began coverage of Israel-based Camtek (NASDAQ:CAMT) with an Outperform rating and a $100 price target. Shares of ...

James Cameron recently called out Christopher Nolan’s Oscar-winning film “Oppenheimer” for being “a moral cop out” in the ...

Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...

DoorDash (DASH) aims for $4.5B EBITDA by 2027 through ad revenue growth & Deliveroo acquisition. Learn about its flexibility ...

A Los Alamos home was featured in one of the biggest summer blockbusters. Now, a group is trying to open it up for the public ...

Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.

James Cameron has hit out at rival director Christopher Nolan ’s Oscar-winning film Oppenheimer, calling it a “moral cop-out” ...

James Cameron addressed Christopher Nolan's Oppenheimer, saying that the film was a 'moral cop out' due to a lack of certain ...